8-K: NHI Executive Severance Agreement Details

National Health Investors, Inc. has entered into a Change in Control Severance Agreement with executive Christian Maingot, outlining terms for potential termination scenarios.

Summary

• National Health Investors, Inc. (NHI) has entered into a Change in Control Severance Agreement (CIC Severance Agreement) with Christian Maingot, effective August 27, 2026.
• The agreement specifies severance benefits for the executive in the event of termination by the Company without Cause or by the Executive for Good Reason within two years following a Change in Control, or termination without Cause within 30 days prior to a Change in Control.
• Severance includes a lump sum cash payment of 2.0 times average annual base salary and bonus, a pro-rated target annual bonus, 18 months of continued COBRA coverage for the executive and spouse, and accelerated vesting of time-based equity awards.
• The agreement also includes non-competition and non-solicitation restrictions for 12 months post-termination if severance is paid, along with ongoing confidentiality obligations.
• Provisions are in place to reduce payments if they would trigger excise taxes, ensuring the executive receives a greater net after-tax amount.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily detailing a standard executive severance agreement rather than significant operational or financial performance changes.

Positives

• Provides clarity and defined terms for executive compensation and severance in specific change-in-control scenarios.
• Ensures continued healthcare coverage for 18 months for the executive and their family.
• Accelerated vesting of equity awards offers continued incentive and retention for the executive.
• The agreement includes provisions to protect the executive from excise taxes on severance payments.

Negatives

• The agreement's terms are contingent on specific termination events (without Cause or for Good Reason) related to a Change in Control, which may not occur.
• Potential for reduced severance payments if they would trigger excise taxes, although the intent is to maximize net proceeds for the executive.

Risks

• The agreement is tied to potential future 'Change in Control' events, the occurrence and timing of which are uncertain.
• Non-competition and non-solicitation clauses may restrict the executive's future employment opportunities.
• The financial impact of potential severance payments on the company is not detailed but could be significant depending on the executive's compensation.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding future financial performance. It focuses solely on the terms of the severance agreement.

Management Comments

• The description of the CIC Severance Agreement is subject to and qualified in its entirety by the full text of the agreement.

Industry Context

StockSavvy.ai notes that executive severance agreements, particularly those tied to change-in-control provisions, are common in the healthcare REIT sector as a means to ensure executive focus and retention during periods of potential corporate transition or acquisition.

Management Changes

Stakeholder Impact

• Shareholders: The agreement provides executive retention and stability during potential transition periods, but could lead to significant payouts if a change in control occurs.
• Employees: The agreement focuses on executive severance; broader employee impacts are not detailed.
• Executive (Christian Maingot): Receives defined severance benefits, continued healthcare, and accelerated equity vesting under specific termination conditions.

Next Steps

• The agreement's terms will be enacted if specific termination conditions related to a Change in Control are met.

Key Dates

Keywords

Severance Agreement, Change in Control, Executive Compensation, Employee Benefits, Corporate Governance, Employment Contract, National Health Investors